131 related articles for article (PubMed ID: 29795081)
1. Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol - Utah, 2017-2018.
Horth RZ; Crouch B; Horowitz BZ; Prebish A; Slawson M; McNair J; Elsholz C; Gilley S; Robertson J; Risk I; Hill M; Fletcher L; Hou W; Peterson D; Adams K; Vitek D; Nakashima A; Dunn A
MMWR Morb Mortal Wkly Rep; 2018 May; 67(20):587-588. PubMed ID: 29795081
[No Abstract] [Full Text] [Related]
2. Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids - Illinois, March-April 2018.
Moritz E; Austin C; Wahl M; DesLauriers C; Navon L; Walblay K; Hendrickson M; Phillips A; Kerins J; Pennington AF; Lavery AM; El Zahran T; Kauerauf J; Yip L; Thomas J; Layden J
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):607-608. PubMed ID: 29851941
[No Abstract] [Full Text] [Related]
3. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
[No Abstract] [Full Text] [Related]
4. Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.
Cordeiro SK; Daro RC; Seung H; Klein-Schwartz W; Kim HK
Addiction; 2018 Oct; 113(10):1850-1861. PubMed ID: 29806885
[TBL] [Abstract][Full Text] [Related]
5. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
Law R; Schier J; Martin C; Chang A; Wolkin A;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
[TBL] [Abstract][Full Text] [Related]
6. Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States.
Roehler DR; Hoots BE; Vivolo-Kantor AM
Drug Alcohol Depend; 2020 Feb; 207():107810. PubMed ID: 31862557
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid poisoning: A growing health concern.
Phillips J; Lim F; Hsu R
Nursing; 2016 Nov; 46(11):34-41. PubMed ID: 27673323
[No Abstract] [Full Text] [Related]
8. An outbreak of exposure to a novel synthetic cannabinoid.
Monte AA; Bronstein AC; Cao DJ; Heard KJ; Hoppe JA; Hoyte CO; Iwanicki JL; Lavonas EJ
N Engl J Med; 2014 Jan; 370(4):389-90. PubMed ID: 24450915
[No Abstract] [Full Text] [Related]
9. Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(46):939. PubMed ID: 24257204
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cannabinoid use in New Zealand: a recent rebound.
Schep LJ; Slaughter RJ; Temple WA; Lambie BS; Gee P; Watts M; Gresham C
N Z Med J; 2012 Oct; 125(1364):114-6. PubMed ID: 23242407
[No Abstract] [Full Text] [Related]
11. Synthetic Cannabinoid-Related Illnesses and Deaths.
Trecki J; Gerona RR; Schwartz MD
N Engl J Med; 2015 Jul; 373(2):103-7. PubMed ID: 26154784
[No Abstract] [Full Text] [Related]
12. Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre.
Schep LJ; Slaughter RJ; Temple WA
N Z Med J; 2011 Dec; 124(1347):99-101. PubMed ID: 22237580
[No Abstract] [Full Text] [Related]
13. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
Dobaja M; Grenc D; Kozelj G; Brvar M
Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
[TBL] [Abstract][Full Text] [Related]
14. Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
Brutlag A; Hommerding H
Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):1087-1102. PubMed ID: 30342565
[TBL] [Abstract][Full Text] [Related]
15. An apparent drop in synthetic cannabinoid presentations.
Mason E
N Z Med J; 2013 Dec; 126(1387):191. PubMed ID: 24362747
[No Abstract] [Full Text] [Related]
16. [Acute cannabis poisoning in a female child].
Renier S; Messi G; Orel P
Minerva Pediatr; 1994; 46(7-8):335-8. PubMed ID: 7935250
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide poisoning in Utah: 1996-2013.
Weaver LK; Deru K; Churchill S; Legler J; Snow G; Grey T
Undersea Hyperb Med; 2016; 43(7):747-758. PubMed ID: 28777512
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
